Sk Bioscience
- All
- News
-
This Is World's Best-Performing IPO In 2021, Raised $1.3 Billion
SK Bioscience's shares are up about 262% since they started trading in Seoul in the first quarter, the most among the 94 major offerings since January.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Bill Gates Says South Korean Firm Could Make 200 Million Vaccines by June
SK Bioscience, the South Korean pharmaceutical company backed by Bill Gates, may be capable of producing 200 million coronavirus vaccine kits by next June, the Microsoft Corp. co-founder said in a letter to South Korean President Moon Jae-in.
-
This Is World's Best-Performing IPO In 2021, Raised $1.3 Billion
SK Bioscience's shares are up about 262% since they started trading in Seoul in the first quarter, the most among the 94 major offerings since January.
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Bill Gates Says South Korean Firm Could Make 200 Million Vaccines by June
SK Bioscience, the South Korean pharmaceutical company backed by Bill Gates, may be capable of producing 200 million coronavirus vaccine kits by next June, the Microsoft Corp. co-founder said in a letter to South Korean President Moon Jae-in.
